Profound Medical to present TULSA Procedure data at AUA2026 and explore PSMA PET integration

Profound Medical Corp.

Four oral presentations on TULSA Procedure at AUA Annual Meeting in Washington, DC on May 16, 2026.
Presenters include Mayo Clinic's Dr. Pathak, Dr. Anttinen (Finland), and Dr. Miura (Japan) covering registry, phase 2 trial, and real-world data.
Launches initiative to explore integration of PSMA PET molecular imaging with TULSA-PRO software for treatment planning and monitoring.
Hosts demonstrations of TULSA-PRO and Siemens MAGNETOM Free.Max MR at booth #413 at AUA2026.
Note: 0.55T MRI compatibility (Free.Max) not yet commercially available in all markets, including the U.S.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.